Two Sigma Advisers
AUXL

Two Sigma Advisers’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Two Sigma Advisers’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-32,717
Closed -$544K – 2577
2013
Q2 		$544K Buy
+32,717
New +$522K 0.01% 1270

Other funds holding AUXL

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Two Sigma Advisers's AUXL Position: Q3 2013 in Review

Two Sigma Advisers sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q3 2013, closing a stake of 32,717 shares — an estimated $544K sold.

Two Sigma Advisers first reported a position in AUXL in Q2 2013 and held it in 1 quarter. The position peaked at $544K in Q2 2013. 150 funds tracked by Wall St. Rank hold AUXL as of Q3 2013.

  • Two Sigma Advisers reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q3 2013 after selling out during the quarter.
  • Two Sigma Advisers sold 32,717 AUXILIUM PHARAMCEUTICALS INC shares in Q3 2013, an estimated $544K.
  • Two Sigma Advisers first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 1 quarter.
  • Two Sigma Advisers's AUXILIUM PHARAMCEUTICALS INC position peaked at $544K in Q2 2013.
  • 150 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q3 2013.

Based on Two Sigma Advisers's 13F filing for Q3 2013, filed 14 Nov 2013.